Agency Information Collection Activities: Submission for OMB Review; Comment Request, 39002-39003 [2019-16986]
Download as PDF
<![CDATA[
39002
Federal Register / Vol. 84, No. 153 / Thursday, August 8, 2019 / Notices
published notice, the NHLBI receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the prospective field of use that are
timely filed in response to this notice
will be treated as objections to the grant
of the contemplated exclusive patent
license. Comments and objections
submitted to this notice will not be
made available for public inspection
and, to the extent permitted by law, will
not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: August 1, 2019.
Michael A. Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34).
Date: September 19, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, Division of Extramural
Activities, Room #3G40, National Institutes
of Health/NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892–7616, 240–669–
5066, pmehrotra@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16965 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2019–16924 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases, Special
Emphasis Panel; Clinical Research Products
Management Center (CRPMC).
Date: September 3, 2019.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Audrey O. Lau, MPH,
Ph.D., Acting Senior Scientific Review
Officer, Aids Review Branch SRP, RM 3E70,
National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9834, Rockville, MD
20852–9834, 240–669–2081, audrey.lau@
nih.gov.
VerDate Sep<11>2014
16:51 Aug 07, 2019
Jkt 247001
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA.
Date: September 11–12, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Director, National Center for Advancing
Translational Sciences (NCATS), National
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4878, 301–435–0813, henriquv@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16925 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: SAMHSA Application for Peer
Grant Reviewers (OMB No. 0930–
0255)—Revision
Section 501(h) of the Public Health
Service (PHS) Act (42 U.S.C. 290aa)
directs the Assistant Secretary of the
Substance Abuse and Mental Health
Services Administration (SAMHSA) to
establish such peer review groups as are
needed to carry out the requirements of
Title V of the PHS Act. SAMHSA
administers a large discretionary grants
program under authorization of Title V,
and, for many years, SAMHSA has
funded grants to provide prevention and
treatment services related to substance
abuse and mental health.
In support of its grant peer review
efforts, SAMHSA desires to continue to
expand the number and types of
reviewers it uses on these grant review
committees. To accomplish that end,
SAMHSA has determined that it is
important to proactively seek the
inclusion of new and qualified
representatives on its peer review
groups. Accordingly, SAMHSA has
developed an application form for use
by individuals who wish to apply to
serve as peer reviewers.
E:\FR\FM\08AUN1.SGM
08AUN1
39003
Federal Register / Vol. 84, No. 153 / Thursday, August 8, 2019 / Notices
The application form has been
developed to capture the essential
information about the individual
applicants. The most consistent method
to accomplish this is through
completion of a standard form by all
interested persons which captures
information about knowledge,
education, and experience in a
consistent manner from all interested
applicants. SAMHSA will use the
information provided on the
applications to identify appropriate peer
grant reviewers. Depending on their
experience and qualifications,
applicants may be invited to serve as
grant reviewers.
The following changes are proposed
in the form:
Under the Target Population Section
—Added the following distinctions:
Tribes or Tribal Organizations
Minorities (African American,
Hispanic/Latino, etc)
Under the Substance Abuse and
Clinical Issues Section
—Added the following distinctions:
Medication Assisted Treatment
Emergency Treatment
Opioid Use Disorders
—Deleted the following distinctions:
Depression/Manic Depression
Ecstasy
Fetal Alcohol Syndrome
Obsessive Compulsive Disorder
Personality Disorders
Under the Other Expertise Section
—Added the following distinctions:
Recovery Support Services
Behavioral Healthcare
Rural Communities
—Deleted the following distinctions:
Faith Based Community Approaches
Violence Prevention Programs
Drug Courts
The following table shows the annual
response burden estimate.
Number of respondents
Responses/respondent
Burden/responses
(hours)
Total burden hours
500
1
1.5
750
Written comments and
recommendations concerning the
proposed information collection should
be sent by September 9, 2019 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2019–16986 Filed 8–7–19; 8:45 am]
BILLING CODE 4162–20–P
jbell on DSK3GLQ082PROD with NOTICES
• Added the collection of License #
and Expiration Date to meet 21st
Century CURES Act requirements.
• Deleted the collection of
experienced federal reviewer or nonfederal reviewer information.
• Under No SAMHSA Experience
section, added collection of whether or
not the potential reviewer had
completed SAMHSA reviewer training
with the date.
VerDate Sep<11>2014
16:51 Aug 07, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Regulations To Implement
SAMHSA’s Charitable Choice Statutory
Provisions—42 CFR Parts 54 and 54a
(OMB No. 0930–0242)—Extension
Section 1955 of the Public Health
Service Act (42 U.S.C. 300x-65), as
amended by the Children’s Health Act
of 2000 (Pub. L. 106–310) and Sections
581–584 of the Public Health Service
Act (42 U.S.C. 290kk et seq., as added
by the Consolidated Appropriations Act
(Pub. L. 106–554)), set forth various
provisions which aim to ensure that
religious organizations are able to
compete on an equal footing for federal
funds to provide substance abuse
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
services. These provisions allow
religious organizations to offer
substance abuse services to individuals
without impairing the religious
character of the organizations or the
religious freedom of the individuals
who receive the services. The provisions
apply to the Substance Abuse
Prevention and Treatment Block Grant
(SABG), to the Projects for Assistance in
Transition from Homelessness (PATH)
formula grant program, and to certain
Substance Abuse and Mental Health
Services Administration (SAMHSA)
discretionary grant programs (programs
that pay for substance abuse treatment
and prevention services, not for certain
infrastructure and technical assistance
activities). Every effort has been made to
assure that the reporting, recordkeeping
and disclosure requirements of the
proposed regulations allow maximum
flexibility in implementation and
impose minimum burden.
No changes are being made to the
regulations or the burden hours.
Information on how states comply
with the requirements of 42 CFR part 54
was approved by the Office of
Management and Budget (OMB) as part
of the Substance Abuse Prevention and
Treatment Block Grant FY 2019–2021
annual application and reporting
requirements approved under OMB
control number 0930–0168.
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 84, Number 153 (Thursday, August 8, 2019)]
[Notices]
[Pages 39002-39003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16986]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Project: SAMHSA Application for Peer Grant Reviewers (OMB No. 0930-
0255)--Revision
Section 501(h) of the Public Health Service (PHS) Act (42 U.S.C.
290aa) directs the Assistant Secretary of the Substance Abuse and
Mental Health Services Administration (SAMHSA) to establish such peer
review groups as are needed to carry out the requirements of Title V of
the PHS Act. SAMHSA administers a large discretionary grants program
under authorization of Title V, and, for many years, SAMHSA has funded
grants to provide prevention and treatment services related to
substance abuse and mental health.
In support of its grant peer review efforts, SAMHSA desires to
continue to expand the number and types of reviewers it uses on these
grant review committees. To accomplish that end, SAMHSA has determined
that it is important to proactively seek the inclusion of new and
qualified representatives on its peer review groups. Accordingly,
SAMHSA has developed an application form for use by individuals who
wish to apply to serve as peer reviewers.
[[Page 39003]]
The application form has been developed to capture the essential
information about the individual applicants. The most consistent method
to accomplish this is through completion of a standard form by all
interested persons which captures information about knowledge,
education, and experience in a consistent manner from all interested
applicants. SAMHSA will use the information provided on the
applications to identify appropriate peer grant reviewers. Depending on
their experience and qualifications, applicants may be invited to serve
as grant reviewers.
The following changes are proposed in the form:
Added the collection of License # and Expiration Date to
meet 21st Century CURES Act requirements.
Deleted the collection of experienced federal reviewer or
non-federal reviewer information.
Under No SAMHSA Experience section, added collection of
whether or not the potential reviewer had completed SAMHSA reviewer
training with the date.
Under the Target Population Section
--Added the following distinctions:
Tribes or Tribal Organizations
Minorities (African American, Hispanic/Latino, etc)
Under the Substance Abuse and Clinical Issues Section
--Added the following distinctions:
Medication Assisted Treatment
Emergency Treatment
Opioid Use Disorders
--Deleted the following distinctions:
Depression/Manic Depression
Ecstasy
Fetal Alcohol Syndrome
Obsessive Compulsive Disorder
Personality Disorders
Under the Other Expertise Section
--Added the following distinctions:
Recovery Support Services
Behavioral Healthcare
Rural Communities
--Deleted the following distinctions:
Faith Based Community Approaches
Violence Prevention Programs
Drug Courts
The following table shows the annual response burden estimate.
----------------------------------------------------------------------------------------------------------------
Number of respondents Responses/respondent Burden/responses (hours) Total burden hours
----------------------------------------------------------------------------------------------------------------
500 1 1.5 750
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent by September 9, 2019 to the
SAMHSA Desk Officer at the Office of Information and Regulatory
Affairs, Office of Management and Budget (OMB). To ensure timely
receipt of comments, and to avoid potential delays in OMB's receipt and
processing of mail sent through the U.S. Postal Service, commenters are
encouraged to submit their comments to OMB via email to:
[email protected]. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2019-16986 Filed 8-7-19; 8:45 am]
BILLING CODE 4162-20-P
